Word: biotechs
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...plans to revolutionize medical care by looking for cure for diseases like Parkinson’s, diabetes, Alzheimer’s and spinal cord injuries, Eli Broad said at the press conference. Broad also said he hopes the institute will serve as a catalyst in the economy of the biotech industry, “that it will foster the creation of jobs and encourage a robust tax base and have a far-reaching and long-lasting economic impact,” he said. Although the Harvard-MIT Broad Institute, created in 2004, also states as its mission finding treatment...
According to David Clapham, Castaneda Professor of Cardiovascular Research at Harvard Medical School and the principal investigator of Kirichok’s lab, understanding the function of CatSper can lead to the development of CatSper blockers to serve as contraceptives. Hydra Biosciences, a biotech company co-founded by Clapham, is already developing a drug that would specifically target CatSper...
...sciences at the National Cancer Institute. But in 2001 the government of Singapore made him an offer he couldn't refuse: the directorship of the brand new Genome Institute along with a $25 million starting budget--part of a $288 million integrated network of life-science research centers and biotech start-ups called Biopolis. Says Liu: "I came because I saw that the entire leadership of the country, the fabric of the country was thirsting for biology...
Venter insists that constant challenge and exposure to new things are what keep his mind sharp at 59. "I thrive on external stimulation," says the man who launched a biotech firm and finished work on his autobiography last year while conducting oceanic research and running the genomic-research institute he founded. "The breadth of what I do continues to expand, which increases the chances of assembling unique views of the world...
...process that can leave companies with promising treatments in limbo for years. "You wouldn't expect a defense contractor to build an aircraft carrier without a contract, but they're expecting pharmaceutical companies to develop these drugs without contracts," says Richard Hollis, CEO of Hollis-Eden, a San Diego biotech hoping to sell the government a treatment for acute radiation syndrome (a blood sickness caused by a dirty bomb or nuclear explosion). Hollis says his company has spent $100 million on the drug, Neumeune, betting the feds would stockpile doses for 12 million to 24 million people. As it turns...